Observational studyFrontiers in immunology2025

Dupilumab for atopic manifestations in pediatric patients with inborn errors of immunity: efficacy and safety in a genetically diverse cohort.

Najla Alsediq et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.